# An-Gong-Niu-Huang-Wan (AGNHW) regulates cerebral blood flow by improving hypoperfusion, cerebrovascular reactivity and microcirculation disturbances after stroke

**Authors:** Xiao Zhang, Jiamin Pei, Luping Xue, Zhe Zhao, Renhao Xu, Cong Zhang, Cong Zhang, Lijie Fu, Xiangjian Zhang, Lili Cui

PMC · DOI: 10.1186/s13020-024-00945-7 · Chinese Medicine · 2024-05-22

## TL;DR

This study shows that An-Gong-Niu-Huang-Wan improves blood flow and recovery after stroke by enhancing microcirculation and regulating vasoactive mediators.

## Contribution

The study reveals AGNHW's novel role in regulating cerebral blood flow and microcirculation after stroke through endothelium-dependent mechanisms.

## Key findings

- AGNHW increased cerebral blood flow and reduced infarct volume after stroke.
- AGNHW improved cerebrovascular reactivity and red blood cell flux in capillaries.
- AGNHW modulated endothelium-dependent vasoactive mediators and gene expression.

## Abstract

The restoration of cerebrovascular regulation and improvement of cerebral blood flow in ischaemic regions are crucial for improving the clinical prognosis after stroke. An-Gong-Niu-Huang-Wan (AGNHW) is a famous traditional compound Chinese medicine that has been used for over 220 years to treat acute ischaemic stroke; however, its role in the regulation of cerebral blood flow is still unclear. The aim of the present study was to investigate the regulatory effect of AGNHW on cerebral blood flow and microcirculation after ischaemic stroke and to elucidate the underlying mechanisms involved.

Male C57BL/6 mice were subjected to distal middle cerebral artery occlusion (dMCAO) and randomly assigned to the sham, MCAO, or AGNHW groups. AGNHW was administered intragastrically 1 h after dMCAO. The rotarod test was utilized to evaluate behavioural function; TTC was used to determine the infarct volume; and ischaemic injury was assessed by detecting brain levels of SOD, MDA and NO. Then, cortical perfusion and acetazolamide-induced cerebrovascular reactivity were assessed using laser speckle contrast imaging, and the velocity and flux of red blood cells in cortical capillaries were detected using two-photon laser scanning microscopy. In addition, we employed RNA-Seq to identify variations in gene expression profiles and assessed endothelium-dependent changes in microcirculatory dysfunction by measuring vasoactive mediator levels.

AGNHW significantly increased cerebral blood flow, reduced the infarct volume, and promoted functional recovery after cerebral ischaemia. AGNHW increased the velocity and flux of red blood cells in capillaries and improved cerebrovascular reactivity in the ischaemic cortex. Furthermore, AGNHW regulated endothelium-dependent microcirculation, as evidenced by decreases in the expression of endothelins (Edn1, Edn3 and Ednrb) and the ratios of brain and serum TXB2/6-keto-PGF1α and ET-1/CGRP.

AGNHW improved cerebral hypoperfusion, regulated cerebrovascular reactivity and attenuated microcirculatory dysfunction within the ischaemic cortex after stroke. This outstanding effect was achieved by modulating the expression of genes related to vascular endothelial cell function and regulating endothelium-dependent vasoactive mediators.

The online version contains supplementary material available at 10.1186/s13020-024-00945-7.

## Linked entities

- **Genes:** EDN1 (endothelin 1) [NCBI Gene 1906], EDN3 (endothelin 3) [NCBI Gene 1908], EDNRB (endothelin receptor type B) [NCBI Gene 1910]
- **Chemicals:** MDA (PubChem CID 1614), NO (PubChem CID 24822), TXB2 (PubChem CID 5283137), 6-keto-PGF1α (PubChem CID 5280888), ET-1 (PubChem CID 11395145), CGRP (PubChem CID 168324612)
- **Diseases:** ischaemic stroke (MONDO:1060198)

## Full-text entities

- **Genes:** EDN1 (endothelin 1) [NCBI Gene 1906] {aka ARCND3, ET1, HDLCQ7, PPET1, QME}, EDNRB (endothelin receptor type B) [NCBI Gene 1910] {aka ABCDS, ET-B, ET-BR, ETB, ETB1, ETBR}, CALCA (calcitonin related polypeptide alpha) [NCBI Gene 796] {aka CALC1, CGRP, CGRP-I, CGRP-alpha, CGRP1, CT}, SOD1 (superoxide dismutase 1) [NCBI Gene 6647] {aka ALS, ALS1, HEL-S-44, IPOA, SOD, STAHP}, EDN3 (endothelin 3) [NCBI Gene 1908] {aka ET-3, ET3, HSCR4, PPET3, WS4B}
- **Diseases:** stroke (MESH:D020521), ischaemic stroke (MESH:D002544), infarct (MESH:D007238), ischaemic cortex (MESH:D054220), cerebral hypoperfusion (MESH:D002547), ischaemic injury (MESH:D014947), cerebral ischaemia (MESH:D002545), ischaemic (MESH:D018917), dMCAO (MESH:D020244)
- **Chemicals:** MDA (MESH:D015104), Chinese medicine (-), acetazolamide (MESH:D000086), NO (MESH:D009614)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11112936/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11112936/full.md

## References

42 references — full list in the complete paper: https://tomesphere.com/paper/PMC11112936/full.md

---
Source: https://tomesphere.com/paper/PMC11112936